Rising levels of serum S100 protein precede other evidence of disease progression in patients with malignant melanoma

Abstract

Thus, rising levels of serum S100 protein are a specific and sensitive clinically relevant marker of tumour progression in melanoma patients, which precedes other evidence of melanoma recurrence.